Pretomanid in the Treatment of Patients with Tuberculosis in the United States

Pretomanid for MDR or XDR Tuberculosis Investigators report findings from the use of an all-oral regimen of bedaquiline, pretomanid, and linezolid in patients in the United States with multidrug-resistant or extensively drug-resistant tuberculosis.